The involvement of the microbiota-gut-brain axis in the pathophysiology of mood disorders and therapeutic implications

Introduction There is a growing body of evidence implicating gut-brain axis dysfunction in the pathophysiology of mood disorders. Accordingly, gut microbiota has become a promising target for the development of biomarkers and novel therapeutics for bipolar and depressive disorders.